H. Kerl
About
In The Last Decade
H. Kerl
158 papers receiving 4.7k citations
Hit Papers
Peers
Comparison fields: 5 of 135
- Dermatology 2.8k
- Oncology 2.0k
- Epidemiology 1.8k
- Pathology and Forensic Medicine 1.4k
- Immunology 763
Countries citing papers authored by H. Kerl
This map shows the geographic impact of H. Kerl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Kerl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Kerl more than expected).
Fields of papers citing papers by H. Kerl
This network shows the impact of papers produced by H. Kerl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Kerl. The network helps show where H. Kerl may publish in the future.
Co-authorship network of co-authors of H. Kerl
This figure shows the co-authorship network connecting the top 25 collaborators of H. Kerl. A scholar is included among the top collaborators of H. Kerl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Kerl. H. Kerl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | A signaling mute hCMV chemokine receptor prevents melanoma growth | 1 |
| 2 | The signaling mute hCMV chemokine receptor US28R129A prevents melanoma growth | 1 |
| 3 | Melanoma. Guidelines for diagnosis and therapy (Das melarnom: Richtlinien fu?r diagnose und therapie) | 1 |
| 4 | Age-related dermoscopic prevalence of Clark nevi | 0 |
| 5 | No evidence for c-erbB-2 overexpression in cutaneous melanoma. | 9 |
| 6 | Erythema migrans multiloculare in an European area endemic for Lyme borreliosis (Styria/Austria). | 1 |
| 7 | Molecular-Detection of Borrelia-Burgdorferi Specific Dna From Central and Peripheral Areas of Erythema Migrans | 2 |
| 8 | Expression of Bcl-2 Protein (Bcl-2) in Cutaneous Neoplasms - An Immunohistochemical Study of 259 Benign and Malignant-Tumors of the Skin | 3 |
| 9 | Molecular Subtyping of Borrelia-Burgdorferi (Bb) in Lesional Skin From Styrian (Austrian) Patients with Various Manifestations of Dermatoborreliosis (Db) | 6 |
| 10 | No Detection of Borrelia-Burgdorferi Specific Dna in Lesions of Erythema Migrans After Treatment with Minocycline | 11 |
| 11 | [Surface microscopy of pigmented cutaneous tumors]. | 19 |
| 12 | Detection of Monoclonal Lymphoid Subpopulations in Clinical Specimens by Pcr and Conformational Polymorphisms of Crna Molecules | 4 |
| 13 | 1 | |
| 14 | 16 | |
| 15 | 92 | |
| 16 | 4 | |
| 17 | Pigmented Skin-Lesions in Xeroderma Pigmentosum | 7 |
| 18 | Hla-Dr Positive Keratinocytes Are Associated with Suppressor-Cell Epidermotropism - a Biomathematical Study | 7 |
| 19 | Nk Cell-Density in Malignant Skin Tumors - a Stereological Study | 1 |
| 20 | 5 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.